We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+40.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$102M
AUM Growth
+$23.6M
Cap. Flow
+$708K
Cap. Flow %
0.7%
Top 10 Hldgs %
41.2%
Holding
109
New
6
Increased
19
Reduced
18
Closed
6

Top Buys

Rank Stock Value
1
VICR icon
Vicor
VICR
+$505K
2
AZTA icon
Azenta
AZTA
+$498K
3
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$434K
4
USAC icon
USA Compression Partners
USAC
+$374K
5
INVE icon
Identive
INVE
+$261K

Top Sells

Rank Stock Value
1
CYRX icon
CryoPort
CYRX
+$631K
2
CYBE
Cyberoptics Corp
CYBE
+$575K
3
AGN
Allergan plc
AGN
+$511K
4
FIS icon
Fidelity National Information Services
FIS
+$234K
5
ACLS icon
Axcelis
ACLS
+$219K

Sector Composition

Rank Sector Weight
1 Technology 27.71%
2 Healthcare 17.53%
3 Financials 10.01%
4 Consumer Discretionary 9.62%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLAB icon
51
Photronics
PLAB
$1.85B
$597K 0.59%
53,600
-300
-0.6% -$3.44K
XPEL icon
52
XPEL
XPEL
$1.24B
$597K 0.59%
38,140
– –
NVS icon
53
Novartis
NVS
$292B
$590K 0.58%
6,760
– –
FAF icon
54
First American
FAF
$7.7B
$583K 0.57%
12,150
– –
RSP icon
55
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$559K 0.55%
5,490
– –
STNG icon
56
Scorpio Tankers
STNG
$3.89B
$556K 0.55%
43,400
– –
CEQP
57
DELISTED
Crestwood Equity Partners LP
CEQP
$544K 0.54%
41,500
– –
IBB icon
58
iShares Biotechnology ETF
IBB
$9.18B
$533K 0.52%
3,900
– –
PIM
59
Franklin Master Intermediate Income Trust
PIM
$150M
$514K 0.51%
125,889
– –
HESM icon
60
Hess Midstream
HESM
$5.23B
$498K 0.49%
27,230
+2,000
+8% +$33.4K
FIX icon
61
Comfort Systems
FIX
$62.3B
$497K 0.49%
12,195
– –
TRGP icon
62
Targa Resources
TRGP
$56.8B
$485K 0.48%
24,173
+1,650
+7% +$24.8K
WMB icon
63
Williams Companies
WMB
$86.1B
$461K 0.45%
24,230
-240
-1% -$4.47K
RDS.A
64
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$461K 0.45%
14,100
– –
FBP icon
65
First Bancorp
FBP
$4.43B
$456K 0.45%
81,600
– –
META icon
66
Meta Platforms (Facebook)
META
$1.5T
$431K 0.42%
1,900
– –
PCTI
67
DELISTED
PCTEL, Inc. Common Stock
PCTI
$430K 0.42%
64,425
– –
EVT icon
68
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
$418K 0.41%
21,739
– –
IMDX
69
Insight Molecular Diagnostics
IMDX
$162M
$412K 0.41%
10,781
– –
OKE icon
70
Oneok
OKE
$55.6B
$400K 0.39%
12,035
+575
+5% +$18.7K
FIT
71
DELISTED
Fitbit, Inc. Class A common stock
FIT
$393K 0.39%
60,850
– –
IDXG
72
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$389K 0.38%
+83,700
New +$434K
EMR icon
73
Emerson Electric
EMR
$86.7B
$378K 0.37%
6,100
– –
DBI icon
74
Designer Brands
DBI
$331M
$365K 0.36%
53,860
– –
VKQ icon
75
Invesco Municipal Trust
VKQ
$537M
$353K 0.35%
30,000
– –
1 2
3
4 5

Similar funds

IWM
IMG Wealth Management Jacksonville, Florida $157M AUM 17.95% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
LAM
Lakewood Asset Management Naperville, Illinois $156M AUM 15.91% 1-Year Est. Return
HAM
Harber Asset Management Asheville, North Carolina $156M AUM 2.37% 1-Year Est. Return
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
CF
CDC Financial Chicago, Illinois $157M AUM

Penbrook Management's Q2 2020 Portfolio in Review

As of Q2 2020, Penbrook Management held 109 positions worth $102M, up 30% from $78.1M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Penbrook Management's Q2 2020 filing shows 6 new, 19 increased, 18 reduced and 6 closed positions. Its largest new stake was Vicor: 9,000 shares worth $648K. The largest sale was CryoPort, an estimated $631K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Penbrook Management's largest Q2 2020 buy was Vicor: 9,000 shares worth $648K.
  • Penbrook Management added most to Azenta in Q2 2020, an estimated $498K increase.
  • Penbrook Management's biggest Q2 2020 reduction was CryoPort, cutting an estimated $631K.
  • Penbrook Management fully exited Allergan plc in Q2 2020, selling an estimated $511K.
  • Penbrook Management's ten largest holdings make up 41% of its $102M portfolio in Q2 2020.
  • Penbrook Management opened 6 new positions and closed 6 in Q2 2020.
  • Penbrook Management's portfolio value rose 30% quarter-over-quarter to $102M.

Based on Penbrook Management's 13F filing for Q2 2020, filed 28 Jul 2020.